TY  - RPRT
TI  - A lenvatinib-resistance-derived transcriptional program identifies metabolic identity remodeling associated with unfavorable survival in hepatocellular carcinoma
AU  - Zheng, L.
AU  - Gan, L.
PY  - 2026
DO  - 10.64898/2026.08.21.746217
UR  - https://www.biorxiv.org/content/10.64898/2026.08.21.746217v1
ID  - 10.64898/2026.08.21.746217
ER  -